Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 38.81%269.06K | -8.30%250.34K | 36.37%416.3K | 224.42%1.27M | 28.29%503.54K | 193.84K | 273.01K | 305.27K | 392.51K | 392.51K |
| Operating revenue | 38.81%269.06K | -8.30%250.34K | 36.37%416.3K | 224.42%1.27M | 28.29%503.54K | --193.84K | --273.01K | --305.27K | --392.51K | --392.51K |
| Cost of revenue | 6.57%153.61K | 7.67%203.39K | 20.87%221.46K | 244.62%849.76K | 41.35%348.55K | 144.14K | 188.9K | 183.22K | 246.58K | 246.58K |
| Gross profit | 132.32%115.46K | -44.17%46.95K | 59.64%194.84K | 190.27%423.61K | 6.21%155K | 49.7K | 84.1K | 122.05K | 145.93K | 145.93K |
| Operating expense | 2.16%149.41K | -23.62%137.66K | -17.76%108.28K | 89.31%594.53K | -41.78%127.69K | 296.84%146.25K | 483.41%180.22K | 394.61%131.67K | 102.92%314.05K | 175.49%219.33K |
| Selling and administrative expenses | 2.16%149.41K | -23.62%137.66K | 99.08%56.8K | 72.22%309.66K | -245.38%-157.18K | 470.99%146.25K | 576.00%180.22K | 46.93%28.53K | 31.42%179.81K | 1.62%108.12K |
| -Selling and marketing expense | -71.79%4.37K | -13.30%8.81K | 91.05%15.42K | 1,022.85%67.26K | --32.56K | --15.48K | --10.16K | --8.07K | --5.99K | ---- |
| -General and administrative expense | 10.92%145.04K | -24.23%128.85K | 102.24%41.39K | 39.46%242.4K | -285.79%-189.74K | 410.55%130.77K | 537.88%170.06K | 5.38%20.46K | 27.05%173.82K | -4.01%102.13K |
| Depreciation amortization depletion | ---- | ---- | -8.74%18.59K | 550.06%123.41K | --34.58K | --22.15K | ---- | --20.37K | --18.99K | ---- |
| -Depreciation and amortization | ---- | ---- | -8.74%18.59K | 550.06%123.41K | --34.58K | --22.15K | ---- | --20.37K | --18.99K | ---- |
| Other taxes | ---- | ---- | -43.95%4.07K | 200.02%16.26K | ---- | ---- | ---- | --7.25K | --5.42K | ---- |
| Other operating expenses | ---- | ---- | -61.82%28.83K | 32.19%145.2K | -153.11%-46.11K | 351.95%50.8K | ---- | 948.58%75.52K | 511.89%109.84K | 424.14%86.81K |
| Operating profit | 64.83%-33.95K | 5.63%-90.7K | 999.78%86.56K | -1.67%-170.93K | 137.20%27.3K | -161.99%-96.55K | -211.16%-96.12K | 63.86%-9.62K | -8.63%-168.12K | 7.81%-73.4K |
| Net non-operating interest income (expenses) | -44.54%-17.8K | -172.67%-24.06K | -94.11%-18.81K | -208.89%-72.52K | -105.52%-41.6K | -664.08%-12.32K | -430.55%-8.82K | -9.69K | -1,032.47%-23.48K | -91,913.64%-20.24K |
| Non-operating interest expense | 44.54%17.8K | 172.67%24.06K | 94.11%18.81K | 208.89%72.52K | 105.52%41.6K | 664.08%12.32K | --8.82K | --9.69K | 1,032.47%23.48K | 876.51%20.24K |
| Other net income (expenses) | -290.8K | -310.8K | 20K | |||||||
| Special income (charges) | ---- | ---- | ---- | ---290.8K | ---- | ---- | ---- | ---- | --0 | ---- |
| -Less:Impairment of capital assets | ---- | ---- | ---- | --310.8K | ---- | ---- | ---- | ---- | --0 | ---- |
| -Less:Other special charges | ---- | ---- | ---- | ---20K | ---- | ---- | ---- | ---- | ---- | ---- |
| Other non-operating income (expenses) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --20K | ---- | ---- |
| Income before tax | 52.46%-51.76K | -9.36%-114.76K | 9,691.04%67.75K | -178.84%-534.24K | -247.19%-325.1K | -183.03%-108.87K | -222.36%-104.94K | 102.60%692 | -22.16%-191.6K | -17.58%-93.64K |
| Income tax | -62.01%1.29K | 3.4K | ||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | 52.46%-51.76K | -9.36%-114.76K | 9,691.04%67.75K | -174.64%-535.53K | -236.36%-326.39K | -183.03%-108.87K | -222.36%-104.94K | 102.60%692 | -24.33%-194.99K | -21.85%-97.04K |
| Net income continuous operations | 52.46%-51.76K | -9.36%-114.76K | 9,691.04%67.75K | -174.64%-535.53K | -236.36%-326.39K | -183.03%-108.87K | -222.36%-104.94K | 102.60%692 | -24.33%-194.99K | -21.85%-97.04K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 52.46%-51.76K | -9.36%-114.76K | 9,691.04%67.75K | -174.64%-535.53K | -236.36%-326.39K | -183.03%-108.87K | -222.36%-104.94K | 102.60%692 | -24.33%-194.99K | -21.85%-97.04K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 52.46%-51.76K | -9.36%-114.76K | 9,691.04%67.75K | -174.64%-535.53K | -236.36%-326.39K | -183.03%-108.87K | -222.36%-104.94K | 102.60%692 | -24.33%-194.99K | -21.85%-97.04K |
| Diluted earnings per share | 63.60%-0.006 | 16.27%-0.0134 | 0.01 | -166.67%-0.08 | -226.13%-0.0497 | -65.76%-0.0166 | -59.78%-0.016 | 0 | 25.00%-0.03 | 23.46%-0.0152 |
| Basic earnings per share | 63.60%-0.006 | 16.27%-0.0134 | 0.01 | -166.67%-0.08 | -226.13%-0.0497 | -65.76%-0.0166 | -59.78%-0.016 | 0 | 25.00%-0.03 | 23.46%-0.0152 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.